Literature DB >> 34726384

Immuno-Enriched Microspheres - Magnetic Blade Spray-Tandem Mass Spectrometry for Domoic Acid in Mussels.

Ariadni Geballa-Koukoula1, Arjen Gerssen1, Marco H Blokland1, Christopher T Elliott2, Janusz Pawliszyn3, Michel W F Nielen1,4.   

Abstract

Paramagnetic microspheres can be used in planar array fluorescence immunoassays for single or multiplex screening of food contaminants. However, no confirmation of the molecular identity is obtained. Coated blade spray (CBS) is a direct ionization mass spectrometry (MS) technique, and when combined with triple quadrupole MS/MS, it allows for rapid confirmation of food contaminants. The lack of chromatography in CBS, though, compromises the specificity of the measurement for unequivocal identification of contaminants, based on the European Union (EU) regulation. Therefore, a rapid and easy-to-use immuno-magnetic blade spray (iMBS) method was developed in which immuno-enriched paramagnetic microspheres replace the coating of CBS. The iMBS-MS/MS method was fully optimized, validated in-house following the EU 2021/808 regulation, and benchmarked against a commercial lateral flow immunoassay (LFIA) for on-site screening of DA. The applicability of iMBS-MS/MS was further demonstrated by analyzing incurred mussel samples. The combination of immunorecognition and MS/MS detection in iMBS-MS/MS enhances the measurement's selectivity, which is demonstrated by the rapid differentiation between the marine toxin domoic acid (DA) and its structural analog kainic acid (KA), which cannot be achieved with the LFIA alone. Interestingly, this first-ever reported iMBS-MS/MS method is generic and can be adapted to include any other immuno-captured food contaminant, provided that monoclonal antibodies are available, thus offering a complementary confirmatory analysis approach to multiplex immunoassay screening methods. Moreover, thanks to its speed of analysis, iMBS-MS/MS can bridge the logistics gap between future large-scale on-site testings using LFIAs and classical time-consuming confirmatory MS analysis performed in official control laboratories.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34726384      PMCID: PMC8637537          DOI: 10.1021/acs.analchem.1c03816

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


Introduction

Liquid or gas chromatography (LC- or GC-) tandem mass spectrometry (MS/MS) is regarded as the gold standard in terms of European regulation on confirmatory analysis of food contaminants.[1−3] However, LC- and GC-MS/MS analysis is time-consuming, which is a drawback for routine laboratories when large numbers of samples often need to be analyzed.[4] Direct and ambient ionization mass spectrometry (AIMS) techniques can be used to shorten analysis time markedly. AIMS enables direct ionization of samples, with minimum or no sample pretreatment, and induces ionization under ambient conditions without chromatographic separation[5] and many times directly from a surface.[6] Just a few examples of such AIMS techniques are direct analysis in real time (DART),[7] desorption electrospray ionization (DESI),[8] and coated blade spray (CBS).[9] DESI and DART were the first AIMS techniques developed[7,8] and support ionization using a constant flow of carrier liquid and gas, respectively. Contrary, CBS employs a coated (on the tip) conductive metal strip, only requiring a small droplet of solvent for desorption and ionization, as in paper spray[10] and modified wooden-tip ESI.[11] The coating on CBS acts as a solid-phase microextraction (SPME) means to achieve selective enrichment of analytes from liquid samples or extracts. Following desorption of the compounds using a drop of organic solvent and high voltage application to the blade, spray ionization occurs without the requirement of additional gas or liquid flows.[9] The CBS’s simplicity enhances the possibilities for future portable CBS-MS applications in food testing.[12,13] CBS’s most recent evolutionary aspect is magnetic blade spray (MBS), where paramagnetic surface-functionalized microparticles have replaced the coating for easy extraction and sample handling.[14] Prior to confirmatory analysis by LC- or GC-MS/MS, rapid screening analysis is often performed.[15] Screening methodologies include biorecognition-based sensors or assays with monoclonal antibodies (mAb), which can provide a quick qualitative or semiquantitative result for the presence of a targeted contaminant or a family of contaminants based on the cross-reactivity profile of the mAb employed. However, screening assays do not provide any structural information on the contaminant detected; thus, confirmatory analysis with LC- or GC-MS/MS is needed in the case of a non-compliant screening result.[15,16] Apart from the well-known lateral flow immunoassay (LFIA),[17,18] many other formats have been developed. Paramagnetic microspheres have been employed in fluorescent (flow)-based screening bioassays. Carboxyl groups on the surface allow for direct covalent coupling of mAb or proteins by EDC/NHS chemistry.[19−21] Combining the features of biorecognition-based screening and direct MS/MS may offer a novel and attractive rapid alternative workflow for confirmatory analysis. Only a few efforts have been made toward this direction of improved testing for contaminants,[22−26] underlining both its novelty and potential applicability. However, no demonstrations of direct immuno-capturing and magnetic blade spray MS (iMBS) for rapid analysis have been published so far. The present study showcases the iMBS approach, where mAbs have been covalently coupled to surface-functionalized paramagnetic microspheres for selective biorecognition and capturing of targeted analytes. Subsequent blade spray and triple quadrupole (QqQ)-MS/MS detection enable the ionization and unequivocal identification of the analytes without additional sample pretreatment. As a proof of concept, the method was developed to detect the marine shellfish toxin domoic acid (DA) and its structural analog, kainic acid (KA) in mussels. DA is an analog of the amino acids glutamate and proline. Specific phytoplankton species produce DA, which bioaccumulates in filter feeders such as shellfish, including scallops, oysters, and mussels. Consumption of DA-contaminated commodities may lead to amnesic shellfish poisoning (ASP); thus, it can cause severe central nervous system symptoms, such as disorientation, seizures, memory loss, and even death.[27,28] The developed iMBS method to screen and confirm the presence of DA was validated according to the 2021 EU legislation[15] at three different target levels (TL) based on the maximum limit (ML) of 20 mg/kg[29] over the course of three days and benchmarked against a commercial LFIA for on-site testing of DA.

Experimental Section

Chemicals and Materials

Acetonitrile and methanol of UHPLC–MS purity grade and ammonia solution (25% v/v), formic acid (98% v/v), acetic acid (98% v/v), and DA and KA were purchased from Merck (Darmstadt, Germany). MilliQ water of 18.3 MΩ/cm conductivity was obtained using a water purification system from Merck (Amsterdam, The Netherlands). Solutions of 5 mM ammonium acetate and 5 mM ammonium formate (Merck) were prepared in MilliQ water. Standard stock solutions of 1000 μg/mL DA, and 5000 μg/mL KA, were prepared in acetonitrile/water (10/90 v/v). For iMBS, polystyrene/divinylbenzene coated blades provided by Restek Corp. (Bellefonte, Pennsylvania, USA) were sonicated at 40 °C in methanol/formic acid (50/50 v/v) for 40 min, to yield non-coated metal blades. The non-coated blades were used for the entire optimization of DA ionization with standard solutions. For adherence of paramagnetic microspheres, a type N48 neodymium magnetic disc (3 mm × 2 mm) from Supermagnete (Gottmadingen, Germany) was positioned under the tip of the non-coated blade. For the immuno-capturing part, MagPlex-C, paramagnetic carboxylated microspheres (MC10038, particle size of 5.6 μm), was purchased from Luminex Corp. (Austin, Texas, USA), and mouse mAbs against DA were provided by Queen’s University Belfast. These antibodies previously demonstrated 24% cross-reactivity with KA but no cross-reactivity toward any naturally co-occurring toxins.[30] As described in the Luminex protocol,[31] a carbodiimide covalent coupling procedure was followed for antibody immobilization on the paramagnetic microspheres. Briefly, 200 μL of stock uncoupled paramagnetic microspheres was washed with MilliQ water and activated using monobasic sodium phosphate (NaH2PO4) (Merck), sulfo-NHS (N-hydroxysulfosuccinimide), and EDC (N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride) (Sigma-Aldrich, Zwijndrecht, The Netherlands). Next, mAbs for DA, 0.15 mg/mL in MES (2-(N-morpholino)ethanesulfonic acid) (Sigma-Aldrich), were added to the activated paramagnetic microspheres for immobilization. After a 2 h incubation, the immuno-enriched paramagnetic microspheres were reconstituted in 200 μL of PBS-TBN (phosphate-buffered saline with Tween-20, bovine serum albumin (BSA), and sodium azide) and stored in the refrigerator at 4 °C in a sealed dark Eppendorf tube. For the preparation of the PBS-TBN stock solution, a PBS solution containing 137 mM sodium chloride (NaCl), 2.7 mM potassium chloride (KCl), 10 mM sodium hydrogen phosphate (Na2HPO4), and 1.8 mM potassium dihydrogen phosphate (KH2PO4) (Merck, Darmstadt, Germany), having a pH of 7.4, was prepared in MilliQ water. The final storage buffer, PBS-TBN, was prepared by 10-fold dilution of the PBS stock solution in MilliQ water containing 0.1% w/v BSA, 0.02% v/v Tween-20, and 0.05% w/v sodium azide (Sigma-Aldrich). For benchmarking, a commercially available LFIA screening test kit for DA, “Reveal 2.0 for ASP”, including LFIAs for DA and micro-perforated filter bags, was purchased from Neogen (Lansing, Michigan, USA). For the in-house validation, 21 blank mussel samples (Mytilus edulis), and for the applicability study, three naturally contaminated (incurred) samples, homogenized and stored at −80 °C, previously analyzed for the presence of DA by validated and accredited routine LC-MS/MS and LC-UV methods, were provided in-house.

Instrumentation

The iMBS-MS/MS analysis was performed on a Micromass Quattro Ultima Pt QqQ-MS (Waters Corporation, Milford, MA, USA) equipped with a blade spray setup consisting of an x-y-z stage and high-voltage plug from a Waters nanoESI ion source. A plastic clamp was used to secure the blade in place (Figure S1). Optimized operating conditions included positive ionization mode with 3.7 kV spray voltage, 50 V cone voltage, 100 °C cone temperature, and 0.16 mL/min argon collision gas flow. Data were acquired in multiple reaction monitoring (MRM) mode, and two transitions were monitored; for DA, m/z 312.1 > 266.1 and m/z 312.1 > 248.1 at 12 eV collision energy, and for KA, m/z 214.1 > 168.1 and m/z 214.1 > 122.1 at 10 and 18 eV collision energies, respectively. The data were acquired and processed using MassLynx software (Waters). From the chronograms acquired, area ion ratios of the two fragment ions for DA and KA were calculated and used for unequivocal confirmation of the identity of each substance according to the criteria.[15]

Methods

For method development and in-house validation, mussel samples were extracted using the previously developed and commercialized Neogen screening assay extraction protocol for efficient extraction of DA from samples.[32] In short, 1 g of the homogenized mussel sample was extracted using 30 mL of water. Vigorous manual agitation followed for 30 s,, and afterward, a micro-perforated filter bag was used to extract further and remove the mussel residues. The final extract was stored in the refrigerator at 4 °C for further use. To validate the iMBS-MS/MS method, portions of the blank mussel extracts were spiked at three different TLs, namely, 335 ng/mL (0.5 × TL), 670 ng/mL (1 × TL), and 1005 ng/mL (1.5 × TL), based on the theoretically calculated DA concentration in sample extracts from mussels contaminated at the ML of 20 mg/kg. For the LFIA screening assay, 100 μL of the extracts was further diluted with the buffer provided in a vial in the assay kit. Finally, 100 μL of the mixture thus obtained was used to develop the LFIA. The same spiked undiluted mussel extracts were also used for iMBS-MS/MS analysis. Ten microliters of the immuno-enriched paramagnetic microspheres suspension was mixed in a 96-well plate with 100 μL of the undiluted mussel extract and 100 μL of MilliQ water. The mixture thus obtained was incubated at room temperature for 10 min. Then, a magnetic plate was positioned underneath the 96-well plate to induce fast sedimentation and adherence of the immuno-enriched paramagnetic microspheres at the bottom of the 96-well plate. The supernatant was discarded, and the magnetically trapped microspheres were washed three times with 100 μL of MilliQ water. For the MS/MS analysis, the non-coated blade was placed at a ±6 mm distance from the entrance cone of the ion source. While the spray voltage was at 0 kV, the incubated and washed paramagnetic microspheres were resuspended in 50 μL of MilliQ water and retrieved from the 96-well plate to be pipetted onto the non-coated metal blade at the tip of the blade with the magnet underneath. Next, after 30 s of adherence time of the paramagnetic microspheres, the excess supernatant liquid was removed with a clean tissue. Then, 4 μL of methanol/formic acid (2.5% v/v) was pipetted on top of the immuno-enriched paramagnetic microspheres to dissociate the antigen from the immobilized antibodies. After 1 min, the binding of the DA from the mAb on the immuno-enriched paramagnetic microspheres has been disrupted, and a second 4 μL aliquot was pipetted because of evaporation of the first 4 μL. Finally, the optimized spray voltage of 3.7 kV was applied to the non-coated blade to obtain an ESI-like spray, and the ions formed were analyzed by MS/MS (Figure ).
Figure 1

Workflow application of iMBS-MS/MS for analysis of contaminated shellfish samples. (A) Shellfish samples are collected on-site. (B) The selected shellfish commodity, i.e., mussels, is homogenized, weighed, and 1 g is extracted with 30 mL of distilled water. (C) The sample extract is further diluted with assay buffer for rapid on-site testing using a commercial screening LFIA, leading to a negative result (two lines, both test and control lines present) for any quantitative result lower than the ML of 20 mg/kg. In contrast, it provides a positive result (control line only) for any readout of equal or more than 20 mg/kg. (D) For a positive or ambiguous result, the same sample extract from step (B) can be used for confirmation using the developed iMBS; the extract is diluted to 1:1 with MilliQ water, and 200 μL of the diluted extract is incubated with 10 μL of immuno-enriched paramagnetic microspheres. (E) After incubation, the final step is the deposition and fixation of the immuno-enriched paramagnetic microspheres on the blade’s tip using a super magnet followed by dissociation with methanol/formic acid (2.5% v/v) and MS/MS confirmatory analysis.

Workflow application of iMBS-MS/MS for analysis of contaminated shellfish samples. (A) Shellfish samples are collected on-site. (B) The selected shellfish commodity, i.e., mussels, is homogenized, weighed, and 1 g is extracted with 30 mL of distilled water. (C) The sample extract is further diluted with assay buffer for rapid on-site testing using a commercial screening LFIA, leading to a negative result (two lines, both test and control lines present) for any quantitative result lower than the ML of 20 mg/kg. In contrast, it provides a positive result (control line only) for any readout of equal or more than 20 mg/kg. (D) For a positive or ambiguous result, the same sample extract from step (B) can be used for confirmation using the developed iMBS; the extract is diluted to 1:1 with MilliQ water, and 200 μL of the diluted extract is incubated with 10 μL of immuno-enriched paramagnetic microspheres. (E) After incubation, the final step is the deposition and fixation of the immuno-enriched paramagnetic microspheres on the blade’s tip using a super magnet followed by dissociation with methanol/formic acid (2.5% v/v) and MS/MS confirmatory analysis.

Results and Discussion

Method Development

Optimization of Blade Spray and MS Conditions

Initial optimization was performed using DA solutions and non-coated blades aiming at optimum ionization and MS operating conditions. Ionization was performed at a distance of ±6 mm between the tip of the blade and the cone inlet of the MS system, to prevent any loss of paramagnetic microspheres by vacuum suction at the final stage of the experimental design. Τhe optimum spray/desorption solution among the solutions tested was that of methanol/formic acid (2.5% v/v). For more information on the optimization of the spray/desorption solution, see the Supporting Information and Figure S2. Furthermore, the matrix interferences were briefly investigated using a methanol/formic acid solution fortified with 0, 0.1, and 1% v/v blank mussel extracts, to mimic an estimate of the matrix residue after three washing cycles of the paramagnetic microspheres at the final experimental iMBS setup. The presence of mussel matrix residues did not alter the resulting chronograms for any of the solutions tested. Finally, the spray voltage, cone voltage, and collision energy were optimized. Optimum conditions included 3.7 kV spray voltage, 50 V cone voltage, and 12 eV collision energy for the MRM transitions m/z 312.1 > 266.1 and m/z 312.1 > 248.1 of DA and 10 and 18 eV for the MRM transitions m/z 214.1 > 168.1 and m/z 214.1 > 122.1 of KA, respectively. For more information on the optimization of the MS operating conditions, see the Supporting Information. When using the mussel extraction protocol (Figure B), the calculated concentration of DA in the extract of a contaminated sample at the TL is approximately 670 ng/mL. Following a 1:1 dilution (Figure D), 33 ng of DA will be theoretically available for incubation with the immuno-enriched paramagnetic microspheres, but only a small fraction of this is expected to bind due to the limited antibody capacity available (Supporting Information). Therefore, the LOD/LOQ in direct MS/MS was assessed over a small dynamic range of 0–12 ng/mL only, using non-coated blades and DA spiked in methanol/formic acid (2.5% v/v) with a 0.1% v/v blank mussel matrix. The limit of quantitation (LOQ) was determined at 2 ng/mL and the limit of detection (LOD) at 0.6 ng/mL. Since no chromatography is applied, it could be argued that the method’s selectivity is compromised in any direct spray-MS/MS method. According to the latest version of the EU legislation 2021/808,[15] for substances with an established ML, four identification points (IPs) are required for the unequivocal identification of contaminants, one of which is obtained from the chromatographic separation and three from the MS/MS detection when two ion transitions are being monitored. It is stated in the EU 2021/808 document that all MS analyses shall be combined with a separation technique “that shows sufficient separation power and selectivity for the specific application”. It may be argued that the high selectivity of immuno-capturing is by far superior versus a generic LC gradient separation using a C18 column, and therefore one IP point could be claimed for iMBS. In combination with the three IPs of MS/MS analysis, unequivocal identification of DA could be obtained using iMBS-MS/MS. To a further extent, according to Berendsen et al.,[33] the selectivity of a direct MS/MS method is assessed by the probability of interference, i.e., P(I) value, which demonstrates the probability of the occurrence of other than the selected compound showing the same MS/MS characteristics. Having chosen the most selective MRM transitions for DA, P(I) is assessed at 4.8 × 10–5, which is still higher than the cutoff P(I) value of 2 × 10–7 for achieving a selective direct MS/MS method. Therefore, it is crucial that a direct MS/MS method features additional selectivity as provided by iMBS discussed in this paper. The immuno-capturing in iMBS adds selectivity to the overall MS/MS method, considering the specificity of the mAb that targets only DA and structural analogs; the latter can be differentiated in MS/MS based on their m/z.

iMBS-MS/MS of Marine Toxins in Shellfish

As a starting point to capture the mAb-coupled paramagnetic microspheres, prototype magnetic blades consisting of a magnetic material with a copper strip for HV application were studied. These magnetic blades were provided by the Pawliszyn group and were previously used in the experimental setup described by Rickert et al.[14] It was noticed that for the same DA solutions tested in the range of 0–12 ng/mL, the signal was lower as compared to the non-coated metal blades used in our blade spray optimization experiments (cf. above), and due to the lower signal, the ion ratios were less robust using these prototype magnetic blades compared to non-coated metal blades (Figure S3). The apparent differences between the prototype magnetic blades and the non-coated metal blades were the conductivity of the material and the tip angle. With the non-coated blade, the entire surface is conductive until the tip end. However, the magnetic prototype material is non-conductive, and to compensate for this lack of conductivity, a copper strip is connected to the blade material. However, the copper strip does not cover the entire surface and, instead, ends a few millimeters away from the tip, resulting in reduced conductivity. In addition, the prototype magnetic blades’ material is not as resistant to deformation as the non-coated blades, causing the tip to be less well defined and sharp. The tip is where the voltage is concentrated at the vertex of the blade, according to the first description of CBS by Gómez-Ríos and Pawliszyn.[9] Changes in the shape of the tip could result in alterations of the spray angle and the accumulation of the voltage, thus applying the same voltage setting in both blades will yield differences in the effective voltage and electric field at the tip. Consequently, we only used non-coated metal blades obtained by the removal of the coating from commercial CBS. Immuno-enriched paramagnetic microspheres were trapped onto these metal blades using a magnetic disc positioned under the tip. The trapping of the microspheres on the blade was characterized by SEM, where differences in the blade surface can be clearly seen between blank (Figure A) and paramagnetic microsphere-enriched surface (Figure B).
Figure 2

SEM images of (A) non-coated magnetic blades and (B) non-coated magnetic blades with captured paramagnetic microspheres.

SEM images of (A) non-coated magnetic blades and (B) non-coated magnetic blades with captured paramagnetic microspheres. In order to develop the final iMBS-MS/MS method, the biorecognition part was optimized with respect to the incubation time needed for binding between the immuno-enriched paramagnetic microspheres and the DA in spiked sample extracts. More specifically, 10 μL of immuno-enriched paramagnetic microspheres was incubated with 200 μL of a 1:1 water dilution of the mussel extract spiked with DA at a level of 670 ng/mL. The tested incubation times were 3, 5, 10, and 20 min. No signal was observed for the MRM transitions of DA when incubating for 3 min, indicating no binding between the mAb and DA. The 5 min incubation produced half the area intensities in the reconstructed MRM chronograms as compared to the 10 min incubation. The latter turned out to be sufficient for quantitative analysis of lower concentrations. No significant changes were observed in the area intensities of the DA MRM transitions for the 10 and 20 min incubations, possibly due to saturation of the immobilized mAbs; therefore, a 10 min incubation was invariably used in the optimized protocol (Figure A). Finally, the amount of immuno-enriched paramagnetic microspheres to be used in each incubation was varied. Incubation for 10 min with 200 μL of 1:1 diluted spiked (670 ng/mL) mussel extract and 5, 10, or 15 μL of paramagnetic microspheres was tested. Five microliters of paramagnetic microspheres produced lower area intensities of the DA MRM transitions than the other volumes tested. Between 10 and 15 μL, similar results were obtained on the area intensities of the DA MRM transitions. However, with the use of 10 μL of immuno-enriched paramagnetic microspheres, one 4 μL drop of dissociation/spray solution onto the blade was sufficient for quantitative dissociation of DA from the immuno-enriched paramagnetic microspheres, and repetitive desorptions did not yield additional signals showing the correct ion ratios. In contrast, with 15 μL of immuno-enriched paramagnetic microspheres, multiple desorption steps are needed for quantitative dissociation. Therefore, 10 μL was found to be the most cost effective and appropriate volume to be used (Figure B).
Figure 3

(A) Overlay chronograms of the m/z 312.1 > 266.1 transition obtained following iMBS-MS/MS, varying in incubation time. (B) Bar graphs of the relative area for the MRM transition m/z 312.1 > 266.1 versus the number of desorption cycles following iMBS-MS/MS, varying in the volume of immuno-enriched paramagnetic microspheres. (C) Overlay chronograms of the m/z 312.1 > 266.1 transition obtained following iMBS-MS/MS using immuno-enriched and unfunctionalized paramagnetic microspheres. For the exact conditions, see text.

(A) Overlay chronograms of the m/z 312.1 > 266.1 transition obtained following iMBS-MS/MS, varying in incubation time. (B) Bar graphs of the relative area for the MRM transition m/z 312.1 > 266.1 versus the number of desorption cycles following iMBS-MS/MS, varying in the volume of immuno-enriched paramagnetic microspheres. (C) Overlay chronograms of the m/z 312.1 > 266.1 transition obtained following iMBS-MS/MS using immuno-enriched and unfunctionalized paramagnetic microspheres. For the exact conditions, see text. To illustrate the feasibility of the iMBS-MS/MS approach, a blank mussel extract was incubated with immuno-enriched paramagnetic microspheres. The same extract was spiked with DA at 670 ng/mL, and next 200 μL of both the blank and fortified 1:1 diluted sample extract were incubated with 10 μL of unfunctionalized paramagnetic microspheres and 10 μL of immuno-enriched paramagnetic microspheres. The results, as expected, showed no signal for the blank sample matrix nor for the unfunctionalized paramagnetic microspheres. In contrast, DA MRM transition signals with the correct ion ratio of 0.29 (i.e., within the ±40% relative deviation from the 0.34 ion ratio for DA[15]) were achieved for the immuno-enriched paramagnetic microspheres incubated with the spiked matrix sample (Figure C). Opposed to the original CBS concept, in iMBS, the sorbent is not permanently bound to the blade but initially suspended in the sample extract. We could argue an arrangement where the immunosorbent is covalently coupled to the blade for simplicity of operation, but the extraction rate in such arrangement might be slower because of mass transfer limitations. Moreover, the option to optimize and/or apply the same immuno-enriched microspheres in a conventional planar array fluorescence immunoassay instrument would be sacrificed in that case.

Initial in-House Method Validations

To validate the developed iMBS-MS/MS approach and the rapid screening LFIA following the recent EU 2021/808 legislation, 21 blank mussel samples were provided in-house, extracted with the LFIA protocol, and the extracts were spiked at three different levels (0.5 × TL, 1 × TL, and 1.5 × TL) and blank. Over the course of three days, seven samples were analyzed each day, and the results of the statistical analysis were used to assess the performance of the methods. Details on how the calculations were performed for the assessment of the validation criteria can be found in the Supporting Information.

Validation of the Screening LFIA Used for Benchmarking

To validate the commercial screening LFIA, the assessment levels were blank, 0.5 × TL, and 1 × TL, because of the inability to differentiate between 1 and 1.5 × TL (Figure A). For a semi-quantitative readout of the LFIAs, a custom 3D printed holder and smartphone readout were used to collect photographs (Figure S4) and measure the intensity of the test (T) and the control (C) lines and calculate the T/C ratio (Supporting Information).
Figure 4

(A) Data analysis of results from 21 blank mussel samples and spiked versions thereof in screening LFIA. On the vertical axis is the intensity of the isolated blue channel of the test line over the control line. (B) Data analysis of results from 21 blank mussel samples and spiked versions thereof in iMBS-MS/MS. (C) iMBS-MS/MS chronograms of the m/z 312.1 > 266.1 transition from paramagnetic microspheres/DA spiked sample at different target levels.

(A) Data analysis of results from 21 blank mussel samples and spiked versions thereof in screening LFIA. On the vertical axis is the intensity of the isolated blue channel of the test line over the control line. (B) Data analysis of results from 21 blank mussel samples and spiked versions thereof in iMBS-MS/MS. (C) iMBS-MS/MS chronograms of the m/z 312.1 > 266.1 transition from paramagnetic microspheres/DA spiked sample at different target levels. Regarding the specificity/sensitivity of the screening LFIA, sufficient discrimination was demonstrated between blank and spiked samples from the 0.5× TL level onward (Figure A and Table S1). Furthermore, based on the (semi-) quantitative smartphone reader, the intra-day repeatability results were 13.7, 10.3, and 13.9% at 0.5 × TL and 15.8, 9.4, and 16.8% at the 1 × TL levels. The inter-day repeatability results were 14.0 and 14.6% at 0.5× and 1 × TL, respectively. Moreover, the within-laboratory reproducibility results were 13.9 and 15.8% at 0.5 × TL and 1 × TL, respectively. The acceptable %RSD value for substances with an ML of >1000 μg/kg is <16%,[15] which means that only one value on the third day of 1 × TL measurements did not comply for a quantitative screening method. Consequently, for the time being, our smartphone-based LFIA for DA should be considered as a semi-quantitative screening method. Moreover, the calculated trueness values were 91 and 112% at the 0.5× and 1 × TL, respectively, and within the acceptance range of 80 to 120% as stated in the legislation.[15] Finally, the CCβ was calculated at 12.8 mg/kg (0.69 ratio T/C).

Validation of the Newly Developed iMBS-MS/MS Method

The use of specific DA antibodies that isolate the analyte of interest, monitoring two MRM transitions, and assessing their ion ratio, assure the iMBS-MS/MS specificity. From the analysis of 21 blank mussel samples, no DA signal was observed, underlining the specificity of the iMBS-MS/MS approach. A clear signal was observed from the 0.5 × TL spiking level onward (Figure B,C). Moreover, the selected MRM transitions monitored and the respective ion ratios (Table S1) enable the confirmation of the identity of DA, without the need of an internal standard (I.S.) (Figure S4). The mean ion ratio for the MRM for DA was 0.34 ± 0.14 (m/z 248.1/266.1) for all the 21 spiked samples analyzed. This ratio is identical to the ion ratio measured for DA in standard methanol/formic acid/mussel solutions. As a result, the ion ratio tolerance limit of the spiked mussel samples analyzed complies with the regulatory requirement of ±40% relative deviation allowed by the EU 2021/808 legislation.[15] Thus, the method is demonstrated to be sufficiently specific/sensitive. The intra-day repeatability results were 5.4, 15.9, and 13.0% at 0.5 × TL, 7.7, 5.0, and 3.9% at 1 × TL, and 5.3, 7.6, and 7.0% at the 1.5 × TL level, for days 1, 2, and 3, respectively. The inter-day repeatability results were 13.7, 7.0, and 7.1% for the 0.5×, 1×, and 1.5 × TL, respectively. Furthermore, the within-laboratory reproducibility results were 13.9, 6.1, and 7.3% at 0.5×, 1×, and 1.5 × TL, respectively. All RSD% values for the validation parameters assessed were lower than 16% and within the acceptance range,[15] underlining the quantitative performance of the developed method in this range and a favorable comparison versus the LFIA screening assay. Moreover, the trueness values were calculated at 103, 104, and 99% for the 0.5×, 1×, and 1.5 × TL, respectively, which is within the acceptance range of 80 to 120%.[15] Finally, the CCα was 23.3 mg/kg, demonstrating that all samples of the 1.5 × TL and above were non-compliant. Therefore, the developed iMBS-MS/MS method has been successfully validated as a quantitative confirmatory method over a limited range around the relevant ML level. The specificity and applicability of the method was further demonstrated by the analysis of KA-spiked and DA-incurred mussel samples. KA is a structural analog of DA but has lower toxicity, and hence the EU does not regulate it. However, KA might interfere with the immuno-capturing in LFIA and iMBS due to its structural similarity. Indeed, using a blank mussel extract spiked with KA at 1005 ng/mL (corresponding to the 1.5 × TL DA level), the LFIA screening test for DA yielded a false-positive result because of the inability of the used mAb to differentiate between structural analogs. However, when using iMBS-MS/MS, it becomes clear that the positive LFIA test result is caused by the presence of KA only since the characteristic ion transitions and respective area ion ratio of 0.34 belonging to DA were absent in the MS/MS data. In contrast, the characteristic product ions belonging to KA were detected with their corresponding area ion ratio of 0.21 (m/z 122.1/168.1) (Figure B and Table ).
Figure 5

Examples of iMBS-MS/MS chronograms of (A) DA-spiked mussel extract and (B) KA-spiked mussel extract. For conditions, see text.

Table 1

Results from iMBS-MS/MS Analysis and LFIA Screening of KA-Spiked Mussel Sample and DA-Incurred Mussel Samplesa

 iMBS-MS/MS
  
 DA
KA
  
sampleion ratiocalculated concentration (mg/kg)ion ratiocalculated concentration (mg/kg)LFIA screening result (T/C)DA concentration based on the reference LC-MS/MS method (mg/kg)
KA spiked mussel extract  0.2127.5b0.21 
incurred mussel #10.3723.5  0.2320.0
incurred mussel #20.3631.5  0.1739.0
incurred mussel #30.3935.6  0.0946.6

The screening result is corrected versus the blank and then the intensity of the test line is divided by the control line (Supporting Information); for the exact conditions, see text.

The calculations of the KA concentration was done with the DA’s calibration curve, under the estimation that the area intensity of the DA’s transition m/z 312.1 > 266.1 is approximately 5 times more intense than that of the KA’s m/z 214.1 > 168.1.

Examples of iMBS-MS/MS chronograms of (A) DA-spiked mussel extract and (B) KA-spiked mussel extract. For conditions, see text. The screening result is corrected versus the blank and then the intensity of the test line is divided by the control line (Supporting Information); for the exact conditions, see text. The calculations of the KA concentration was done with the DA’s calibration curve, under the estimation that the area intensity of the DA’s transition m/z 312.1 > 266.1 is approximately 5 times more intense than that of the KA’s m/z 214.1 > 168.1. Finally, following the workflow described in Figure , three DA-incurred mussel samples originating from the Netherlands were analyzed both by the screening LFIAs and the newly developed iMBS-MS/MS method. The results were similar to those of the accredited LC-MS/MS and LC-UV methods for DA. The LFIAs, showed positive results and high contamination levels beyond 1 × TL according to semi-quantitative smartphone analysis. Also, the iMBS-MS/MS results were in accordance with previous results from the independent reference method. For incurred mussel samples #1 and #2, the estimated concentration was close to the analysis result of the reference method. For the incurred mussel #3, probably because of saturation of the immobilized mAbs on the paramagnetic microspheres, the estimated concentration according to iMBS-MS/MS was somewhat lower but in accordance with the limited dynamic range of an immuno-capturing method. In all cases, however, the iMBS-MS/MS results correctly characterized the analyzed samples as non-compliant and containing DA, confirmed by the respective ion ratio for DA (m/z 248.1/266.1) within the 0.34 ± 40% tolerance limit set by the legislation,[15] and not containing the harmless KA (Table ).

Conclusions

Ambient and direct ionization mass spectrometric techniques are rapid tools for detecting numerous substances, as many applications demonstrate. However, their inherent lack of chromatographic separation leads to their exclusion as confirmatory methods in EU food-safety schemes, as they do not meet the standards laid down in legislation. In this work, we have demonstrated the development of an iMBS-MS/MS confirmatory analysis method and its validation according to the very recently revised EU legislation. Moreover, we showed that iMBS-MS/MS rapidly identifies false-positive LFIA screening results caused by harmless unregulated structure analogs. The iMBS exploits the use of mAbs for selective isolation of the analyte of interest, adding substantially to the overall specificity of the rapid direct MS/MS approach, thereby competing with time-consuming regulatory LC-MS/MS methods. An additional IP should be granted in future revisions of the legislation, because of the “immuno-chromatography” nature of the iMBS-MS/MS approach. The developed method is generic, reproducible, and quantitative without employing an I.S. and could be applied to any MS-amenable analyte, provided that a pair of antigen/antibody is available. Moreover, different sets of immuno-enriched paramagnetic microspheres with antibodies aiming at different analytes could lead to multiplex iMBS-MS/MS confirmatory analysis opportunities, complementary to multiplex planar array immuno assays used for parallel screening of routine samples.
  24 in total

1.  Versatile new ion source for the analysis of materials in open air under ambient conditions.

Authors:  Robert B Cody; James A Laramée; H Dupont Durst
Journal:  Anal Chem       Date:  2005-04-15       Impact factor: 6.986

2.  Interface for Online Coupling of Surface Plasmon Resonance to Direct Analysis in Real Time Mass Spectrometry.

Authors:  Yiding Zhang; Xianjiang Li; Honggang Nie; Li Yang; Ze Li; Yu Bai; Li Niu; Daqian Song; Huwei Liu
Journal:  Anal Chem       Date:  2015-06-23       Impact factor: 6.986

3.  Highly Integrated Microfluidic Chip Coupled to Mass Spectrometry for Online Analysis of Residual Quinolones in Milk.

Authors:  Yaju Zhao; Minmin Tang; Fei Liu; Hui Li; Haiyan Wang; Danke Xu
Journal:  Anal Chem       Date:  2019-10-15       Impact factor: 6.986

Review 4.  Ambient (desorption/ionization) mass spectrometry methods for pesticide testing in food: a review.

Authors:  Miriam Beneito-Cambra; Bienvenida Gilbert-López; David Moreno-González; Marcos Bouza; Joachim Franzke; Juan F García-Reyes; Antonio Molina-Díaz
Journal:  Anal Methods       Date:  2020-10-22       Impact factor: 2.896

5.  Multidetection of paralytic, diarrheic, and amnesic shellfish toxins by an inhibition immunoassay using a microsphere-flow cytometry system.

Authors:  María Fraga; Natalia Vilariño; M Carmen Louzao; Paula Rodríguez; Katrina Campbell; Christopher T Elliott; Luis M Botana
Journal:  Anal Chem       Date:  2013-07-31       Impact factor: 6.986

6.  Electrospray Ionization on Solid Substrates.

Authors:  Pui-Kin So; Bin Hu; Zhong-Ping Yao
Journal:  Mass Spectrom (Tokyo)       Date:  2014-05-01

Review 7.  Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages.

Authors:  Briza Pérez-López; Mònica Mir
Journal:  Talanta       Date:  2020-12-03       Impact factor: 6.556

8.  Direct analysis of lateral flow immunoassays for deoxynivalenol using electrospray ionization mass spectrometry.

Authors:  Ariadni Geballa-Koukoula; Arjen Gerssen; Michel W F Nielen
Journal:  Anal Bioanal Chem       Date:  2020-08-28       Impact factor: 4.142

9.  From Smartphone Lateral Flow Immunoassay Screening to Direct MS Analysis: Development and Validation of a Semi-Quantitative Direct Analysis in Real-Time Mass Spectrometric (DART-MS) Approach to the Analysis of Deoxynivalenol.

Authors:  Ariadni Geballa-Koukoula; Arjen Gerssen; Michel W F Nielen
Journal:  Sensors (Basel)       Date:  2021-03-07       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.